BUPARLISIB for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 5 adverse event reports in the FDA FAERS database where BUPARLISIB was used for Neoplasm malignant.

Most Reported Side Effects for BUPARLISIB

Side Effect	Reports	%	Deaths	Hosp.
Hyperglycaemia	13	13.7%	0	3
Diarrhoea	11	11.6%	0	4
Alanine aminotransferase increased	10	10.5%	0	0
Depression	10	10.5%	0	1
Product use in unapproved indication	10	10.5%	3	9
Anxiety	9	9.5%	0	1
Asthenia	8	8.4%	0	4
Fatigue	8	8.4%	0	3
Rash	8	8.4%	0	1
Nausea	7	7.4%	0	2
Aspartate aminotransferase increased	6	6.3%	0	0
Mucosal inflammation	6	6.3%	2	3
Neutropenia	6	6.3%	1	1
Rash maculo-papular	6	6.3%	1	1
Anaemia	5	5.3%	0	1